Summary
Five glycoproteins have been measured in the blood of 145 diabetic patients with and without clinical evidence of complications. Patients with diabetic complications have higher glycoprotein levels particularly when expressed as a ratio to serum albumin levels. In 32 pairs of patients matched for age, sex, body weight, duration and treatment of diabetes, significantly higher haptoglobin, fibrinogen and caeruloplasmin levels were associated with the presence of diabetic complications, but blood glucose levels were not significantly different, β-lipoprotein levels were positively correlated with age and α2-macroglobulin levels with the duration of clinical disease, but the type of antidiabetic therapy administered did not significantly alter glycoprotein levels. It is suggested that rising levels of certain glycoproteins in the blood of diabetic patients may indicate the development of diabetic vascular complications, but a prospective study is required before it can be decided whether this change predates the clinical appearance of the complications.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Koj, A.: Structure and function of plasma proteins. Vol. 1., pp. 73–131. London: Plenum Press 1974
McMillan, D. E.: Association of diabetic microangiopathy with serum haptoglobin and albumin levels. Diabetes 27 (Suppl. 1), 289 (1973)
Ditzel, J.: Functional microangiopathy in diabetes mellitus. Diabetes 17, 388–397 (1968)
Goldenberg, S., Alex, M., Joski, R. A., Blumenthal, H. T.: Nonatheromatous peripheral vascular disease of the lower extremity in diabetes mellitus. Diabetes 8, 261–273 (1959)
Kemsley, W. F. F.: Body weight at different ages and heights. Ann. Eugen. (Lond.) 16, 316–334 (1951)
Shepherd, D., Jonsson, A.: A semiautomated method for the estimation of serum haptoglobin levels. Analyt. Biochem. (Submitted for publication 1976)
Mancini, G., Carbonara, A., Heremanns, J. F.: Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2, 235–254 (1965)
Ratnoff, O. D., Menzie, C.: A new methods for the determination of fibrinogen in small samples of plasma. J. Lab. clin. Med. 37, 316–320 (1951)
Bernsten, M., Samaille, J.: Dosage des β-lipoproteines seriques apres precipitation selective per L'heparine. Presse méd. 66, 974–975 (1958)
Watson, D.: A simple method for the determination of serum cholesterol. Clin. chim. Acta 5, 637–642 (1960)
Spiro, R. G.: Glycoproteins, structure, metabolism and biology. New Engl. J. Med. 269, 566–573, 616–621 (1963)
Schertenleib, F., Tuller, E. F.: Paper electrophoresis of serum proteins in diabetic patients. Diabetes 7, 46–52 (1958)
Ejarque, P., Marble, A., Tuller, E. F.: Proteins, lipoproteins and protein-bound carbohydrates in the serums of diabetic patients. Amer. J. Med. 27, 221–230 (1959)
McMillan, D. E.: Changes in serum proteins and protein bound carbohydrates in the serums of diabetic patients. Diabetologia 6, 597–604 (1970)
Bergstrand, C. G., Furst, P., Larsson, Y., Sterky, G.: Serum haptoglobin in juvenile diabetes. Scand. J. clin. Lab. Invest. 14, 629–632 (1962)
Ganrot, P. O., Gydell, K., Ekelund, H.: Serum concentration of α2-macroglobin, haptoglobin and α1-antitrypsin in diabetes mellitus. Acta endocr. (Kbh.) 55, 537–544 (1967)
Wardle, E. M., Piercy, D. A., Andersen, J.: Some chemical indices of diabetic vascular disease. Postgrad. med. J. 49, 1–9 (1973)
Cleve, H., Alexander, K., Mitzkat, J. H., Nissen, P., Salzmann, I.: Serum Glykoproteine beim Diabetes mellitus; quantitative immunologische Bestimmung von saurem α1-Gykoprotein, Gc, α2-Makroglobin und Hämopexin bei Diabetikern mit und ohne Angiopathien. Diabetologia 4, 48–55 (1968)
Müller, H., Kluthe, R.: Das Verhalten verschiedener Alpha2-Globuline beim Diabetes mellitus. Med. Klin. 66, 522–526 (1971)
Levin, N. W., Cortes, P., Silveira, E., Rubenstein, A. H.: Relation of renal growth to diabetic glomerulosclerosis. Lancet 1975 I, 1120–1121
Boston Collaborative Drug Surveillance Program: Relation between insulin induced hypoglycaemia and serum haptoglobin levels. Diabetes 23, 151–153 (1972)
Durr, H., Kallee, E.: Wechselwirkungen zwischen 131I-Insulin und α2-Macroglobulin. Hoppe-Seylers Z. physiol. Chem. 352, 629–634 (1971)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jonsson, A., Wales, J.K. Blood glycoprotein levels in diabetes mellitus. Diabetologia 12, 245–250 (1976). https://doi.org/10.1007/BF00422091
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00422091